Found: 4
Select item for more details and to access through your institution.
Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 5, p. 634, doi. 10.1111/j.1365-2141.2011.08757.x
- By:
- Publication type:
- Article
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapoc (ICA-17043)
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 1, p. 92, doi. 10.1111/j.1365-2141.2010.08520.x
- By:
- Publication type:
- Article
Dose-Escalation Study of ICA-17043 in Patients with Sickle Cell Disease.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 11, p. 1557, doi. 10.1592/phco.26.11.1557
- By:
- Publication type:
- Article
Haemoglobin response to senicapoc in patients with sickle cell disease: a re‐analysis of the Phase III trial.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 5, p. e129, doi. 10.1111/bjh.17345
- By:
- Publication type:
- Article